Biopharmaceutical company Quantum BioPharma (QNTM) has seen its stock rocket up roughly 230% in the past month. The company ...

MZ will work closely with Quantum BioPharma management to develop and implement a comprehensive capital markets strategy designed to increase the Company’s visibility throughout the investment ...

This is the second successful treatment in a donkey, demonstrating the potential of Innocan's Liposomal CBD injection for human and veterinary use HERZLIYA, Israel and CALGARY, AB, Feb. 10, 2025 ...

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.

The pharmaceutical industry is at a pivotal moment. Artificial intelligence (AI) is shifting from improving processes to reshaping disease treatment and care delivery. Early adopters are seeing ...

There was an early penalty flag in Super Bowl LIX that went the Chiefs' way, and social media, right on cue, went ablaze. On 4th-and-2, the Eagles opted to keep the offense on the field, and Jalen ...

Rocket Pharmaceuticals (RCKT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising ...

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", or the "Company"), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., ("HOPE ...

Cooper DeJean’s Super Bowl birthday got that much more special in the second quarter on Sunday. The rookie cornerback, who turned 22 on Sunday, has been a young star for the Eagles secondary ...

The Detroit Lions came up short of their biggest goal, but enjoyed a banner season in 2024. While the overwhelming sentiment will ultimately be disappointment with the team not reaching the Super ...

LAKELAND, Fla. — The Detroit Tigers didn't plan to sign right-hander Jack Flaherty in free agency. Flaherty wanted a long-term, nine-figure contract that the Tigers weren't interested in ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...